Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study

Maria Cristina Vedovati; Michela Giustozzi; Paolo Verdecchia; Lucia Pierpaoli; Serenella Conti; Melina Verso; Francesco Di Filippo; Emanuela Marchesini; Giulio Bogliari; Giancarlo Agnelli; Cecilia Becattini

doi:10.1016/j.ijcard.2018.07.138

Related publications

Article2017

P4621Patients with cancer and atrial fibrillation treated with NOACs: data from a prospective cohort

Maria Cristina Vedovati, Michela Giustozzi, P. Verdecchia, Lucia Pierpaoli, Serenella Conti, Melina Verso, Esmeralda Filippucci, Alessandra Ascani, Giulio Bogliari, Giancarlo Agnelli, Cecilia Becattini

Article2018

Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study

Paolo Verdecchia, Maria Cristina Vedovati, Serenella Conti, Michela Giustozzi, Adolfo Aita, Gabriella Molini, Fabio Angeli, Darío Turturiello, Cecilia Becattini, Claudio Cavallini, Giancarlo Agnelli

Article2019

Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study

Maria Cristina Vedovati, Alessandra Mancuso, Lucia Pierpaoli, Ugo Paliani, Serenella Conti, Alessandra Ascani, Giulia Galeotti, Francesco Di Filippo, Carla Caponi, Giancarlo Agnelli, Cecilia Becattini

Article2019

P3472Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study

Daniele Pastori, Professor Gregory Lip, Angela Sciacqua, Francesco Perticone, Francesco Melillo, Cosmo Godino, Rossella Marcucci, Martina Berteotti, Francesco Violi, Pasquale Pignatelli

Article2020

Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation

Michela Giustozzi, Matteo Mazzetti, Maurizio Paciaroni, Giancarlo Agnelli, Cecilia Becattini, Maria Cristina Vedovati